591 related articles for article (PubMed ID: 20193038)
1. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.
Blard O; Feuillette S; Bou J; Chaumette B; Frébourg T; Campion D; Lecourtois M
Hum Mol Genet; 2007 Mar; 16(5):555-66. PubMed ID: 17309878
[TBL] [Abstract][Full Text] [Related]
3. Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.
Talmat-Amar Y; Arribat Y; Redt-Clouet C; Feuillette S; Bougé AL; Lecourtois M; Parmentier ML
Hum Mol Genet; 2011 Oct; 20(19):3738-45. PubMed ID: 21705366
[TBL] [Abstract][Full Text] [Related]
4. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
[TBL] [Abstract][Full Text] [Related]
5. Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.
Cowan CM; Chee F; Shepherd D; Mudher A
Biochem Soc Trans; 2010 Apr; 38(2):564-70. PubMed ID: 20298222
[TBL] [Abstract][Full Text] [Related]
6. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
[TBL] [Abstract][Full Text] [Related]
7. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
8. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
Fulga TA; Elson-Schwab I; Khurana V; Steinhilb ML; Spires TL; Hyman BT; Feany MB
Nat Cell Biol; 2007 Feb; 9(2):139-48. PubMed ID: 17187063
[TBL] [Abstract][Full Text] [Related]
9. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
Paquet D; Schmid B; Haass C
Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
[TBL] [Abstract][Full Text] [Related]
10. Anatamopathological spectrum of tauopathies.
Revesz T; Holton JL
Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
[TBL] [Abstract][Full Text] [Related]
11. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
12. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
13. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
15. Role of tau protein in both physiological and pathological conditions.
Avila J; Lucas JJ; Perez M; Hernandez F
Physiol Rev; 2004 Apr; 84(2):361-84. PubMed ID: 15044677
[TBL] [Abstract][Full Text] [Related]
16. Study of tauopathies by comparing Drosophila and human tau in Drosophila.
Chen X; Li Y; Huang J; Cao D; Yang G; Liu W; Lu H; Guo A
Cell Tissue Res; 2007 Jul; 329(1):169-78. PubMed ID: 17406902
[TBL] [Abstract][Full Text] [Related]
17. Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly.
Feijoo C; Campbell DG; Jakes R; Goedert M; Cuenda A
J Cell Sci; 2005 Jan; 118(Pt 2):397-408. PubMed ID: 15632108
[TBL] [Abstract][Full Text] [Related]
18. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
[TBL] [Abstract][Full Text] [Related]
19. Interneuronal transfer of human tau between Lamprey central neurons in situ.
Kim W; Lee S; Jung C; Ahmed A; Lee G; Hall GF
J Alzheimers Dis; 2010; 19(2):647-64. PubMed ID: 20110609
[TBL] [Abstract][Full Text] [Related]
20. [Animal models of tauopathies].
Higuchi M
Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
